Medical News Today: What's to know about acitretin?
Acitretin is a prescription drug. It is available as an oral capsule and as a brand-name drug called Soriatane, as well as in generic form, and is effective for treating severe psoriasis. The drug carries an FDA Black Box warning, so there are safety precautions to consider before taking acitretin. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 27, 2018 Category: Consumer Health News Tags: Pharmacy / Pharmacist Source Type: news

Soriatane (Acitretin) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 16, 2017 Category: Drugs & Pharmacology Source Type: news

Acitretin (Soriatane) Capsules (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - July 24, 2017 Category: Drugs & Pharmacology Source Type: news

Soriatane (acitretin)
Title: Soriatane (acitretin)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 11/16/2016 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - November 16, 2016 Category: Dermatology Source Type: news

acitretin (Soriatane)
Title: acitretin (Soriatane)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 6/22/2016 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - June 22, 2016 Category: Dermatology Source Type: news

Can acitretin be given to patients with renal impairment or patients on renal replacement therapies?
Source: South West Medicines Information and Training Area: Evidence> Medicines Q & A There are very few data to support the use of acitretin in patients with renal impairment (RI) or in those undergoing renal replacement therapy (RRT) and further studies are needed. The information that is available is conflicting. Acitretin should only be prescribed by, or under the supervision of a dermatological specialist. The decision to prescribe acitretin to a patient with RI or on RRT lies with the physician and should be based on an appropriate assessment of the likely risk versus benefit ratio. If acitretin is prescrib...
Source: NeLM - Medicines Q and A - January 8, 2013 Category: Drugs & Pharmacology Source Type: news